Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lower Extremity | 5 | 2019 | 100 | 1.020 |
Why?
|
| After-Hours Care | 1 | 2019 | 6 | 0.610 |
Why?
|
| Hospital Costs | 1 | 2019 | 48 | 0.590 |
Why?
|
| Operating Rooms | 1 | 2019 | 41 | 0.580 |
Why?
|
| Patient Care Team | 1 | 2019 | 124 | 0.560 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2014 | 61 | 0.530 |
Why?
|
| Seroma | 1 | 2011 | 5 | 0.350 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 11 | 0.350 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 19 | 0.330 |
Why?
|
| Vena Cava, Inferior | 1 | 2010 | 28 | 0.320 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 88 | 0.310 |
Why?
|
| Sarcoma | 1 | 2010 | 92 | 0.310 |
Why?
|
| Accidental Falls | 1 | 2010 | 104 | 0.300 |
Why?
|
| Hand Strength | 2 | 2020 | 98 | 0.290 |
Why?
|
| Vascular Diseases | 2 | 2020 | 66 | 0.280 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2014 | 82 | 0.280 |
Why?
|
| Aged | 14 | 2020 | 10260 | 0.260 |
Why?
|
| Saphenous Vein | 2 | 2017 | 22 | 0.250 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 256 | 0.250 |
Why?
|
| Retrospective Studies | 8 | 2020 | 3624 | 0.240 |
Why?
|
| Male | 15 | 2020 | 19437 | 0.220 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2014 | 51 | 0.200 |
Why?
|
| Renal Artery Obstruction | 2 | 2014 | 38 | 0.200 |
Why?
|
| Vascular Patency | 3 | 2017 | 66 | 0.190 |
Why?
|
| Treatment Outcome | 7 | 2017 | 3416 | 0.180 |
Why?
|
| Middle Aged | 10 | 2019 | 11848 | 0.180 |
Why?
|
| Female | 14 | 2020 | 19942 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 907 | 0.170 |
Why?
|
| Humans | 17 | 2020 | 32274 | 0.170 |
Why?
|
| Time Factors | 4 | 2019 | 2204 | 0.160 |
Why?
|
| Risk Factors | 7 | 2020 | 3934 | 0.160 |
Why?
|
| Models, Economic | 1 | 2019 | 18 | 0.150 |
Why?
|
| Specialization | 1 | 2019 | 30 | 0.150 |
Why?
|
| Cost Savings | 1 | 2019 | 34 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2020 | 204 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 191 | 0.140 |
Why?
|
| Amputation | 1 | 2018 | 44 | 0.140 |
Why?
|
| Psoas Muscles | 1 | 2017 | 16 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2019 | 179 | 0.130 |
Why?
|
| Sarcopenia | 1 | 2017 | 50 | 0.130 |
Why?
|
| Marital Status | 1 | 2017 | 21 | 0.130 |
Why?
|
| Aortography | 2 | 2014 | 16 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2020 | 823 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 44 | 0.120 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2016 | 9 | 0.120 |
Why?
|
| Celiac Artery | 1 | 2016 | 6 | 0.120 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2016 | 12 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2017 | 114 | 0.120 |
Why?
|
| Angioplasty, Balloon | 1 | 2016 | 31 | 0.120 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 883 | 0.120 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 27 | 0.110 |
Why?
|
| Stents | 2 | 2016 | 159 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 128 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 51 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 1223 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 131 | 0.110 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 651 | 0.110 |
Why?
|
| Renal Circulation | 1 | 2014 | 12 | 0.100 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 11 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 183 | 0.100 |
Why?
|
| Furosemide | 1 | 2014 | 8 | 0.100 |
Why?
|
| Polyethylene Terephthalates | 1 | 2013 | 3 | 0.100 |
Why?
|
| Rifampin | 1 | 2013 | 7 | 0.100 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 7 | 0.100 |
Why?
|
| Renal Artery | 1 | 2014 | 47 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 38 | 0.100 |
Why?
|
| Software | 1 | 2014 | 124 | 0.100 |
Why?
|
| Oxygen | 1 | 2014 | 138 | 0.100 |
Why?
|
| Angioplasty | 1 | 2012 | 29 | 0.090 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 24 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2012 | 30 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2015 | 319 | 0.090 |
Why?
|
| Ischemia | 1 | 2012 | 115 | 0.090 |
Why?
|
| Edema | 1 | 2011 | 29 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 324 | 0.090 |
Why?
|
| Second-Look Surgery | 1 | 2010 | 3 | 0.080 |
Why?
|
| Phlebography | 1 | 2010 | 26 | 0.080 |
Why?
|
| Hematoma | 1 | 2010 | 26 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 43 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2010 | 60 | 0.080 |
Why?
|
| Balloon Occlusion | 1 | 2010 | 36 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1437 | 0.080 |
Why?
|
| Reoperation | 1 | 2011 | 252 | 0.080 |
Why?
|
| Comorbidity | 3 | 2017 | 565 | 0.080 |
Why?
|
| Mesentery | 1 | 2009 | 6 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 85 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2010 | 164 | 0.080 |
Why?
|
| Necrosis | 1 | 2009 | 54 | 0.080 |
Why?
|
| Cause of Death | 2 | 2020 | 236 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2020 | 2316 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 3898 | 0.070 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2006 | 2 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 287 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 1534 | 0.050 |
Why?
|
| Linear Models | 2 | 2017 | 425 | 0.050 |
Why?
|
| Child | 1 | 2010 | 2434 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 2240 | 0.050 |
Why?
|
| Registries | 2 | 2017 | 294 | 0.050 |
Why?
|
| Recurrence | 2 | 2016 | 285 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2014 | 106 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 743 | 0.050 |
Why?
|
| United States | 2 | 2020 | 4072 | 0.040 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2017 | 10 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 32 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 150 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 893 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2017 | 69 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2017 | 22 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1179 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 456 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 42 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 45 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 484 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 355 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 335 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 47 | 0.030 |
Why?
|
| Career Choice | 1 | 2015 | 43 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 773 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 955 | 0.030 |
Why?
|
| Perception | 1 | 2015 | 99 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 413 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 655 | 0.030 |
Why?
|
| North Carolina | 1 | 2017 | 1300 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 96 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1479 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 200 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 65 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 276 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 132 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 9256 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 272 | 0.020 |
Why?
|
| Critical Illness | 1 | 2012 | 87 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 757 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 321 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 555 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 1425 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 125 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 1010 | 0.010 |
Why?
|